Renal Modulation: Arginine Vasopressin and Atrial Natriuretic Peptide

Nephrology and Fluid/Electrolyte Physiology: Neonatology Questions and Controversies

Volumn , Issue , 2008, Pages 128-146

  Zaffanello, Marco ^a   Procaccino, Maria Antonietta ^b   Stringini, Gilda ^b   Emma, Francesco ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904228079     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3163-5.50014-2     Document Type: Chapter

References (191)

1. Goodman BE Transport of small molecules across cell membranes: water channels and urea transporters. Adv Physiol Educ 2002, 26:146.
2. Shaffer SG, Weisman DN Fluid requirements in the preterm infant. Clin Perinatol 1992, 19:233.
3. Robertson GL, Berl T. Pathophysiology of water metabolism. In Brenner BM (ed.): The Kidney, 5th edn (Philadelphia, PA: Saunders), pp. 873-928, 1996.
4. Miyata S, Takamatsu H, Maekawa S, et al. Plasticity of neurohypophysial terminals with increased hormonal release during dehydration: ultrastructural and biochemical analyses. J Comp Neurol 2001, 434:413.
5. Hoffman GE, McDonald T, Figueroa JP, Nathanielsz PW Neuropeptide cells and fibers in the hypothalamus and pituitary of the fetal sheep: comparison of oxytocin and arginine vasopressin. Neuroendocrinology 1989, 50:633.
6. Hammer M, Olgaard K, Schapira A, et al. Hypovolemic stimuli and vasopressin secretion in man. Acta Endocrinol 1988, 118:465.
7. Engelmann M, Ludwig M The activity of the hypothalamo-neurohypophysial system in response to acute stressor exposure: neuroendocrine and electrophysiological observations. Stress 2004, 7:91.
8. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990, 70:665.
9. Toto KH Regulation of plasma osmolality: thirst and vasopressin. Crit Care Nurs Clin North Am 1994, 6:661.
10. Mannix ET, Farber MO, Aronoff GR, et al. Hemodynamic, renal, and hormonal responses to lower body positive pressure in human subjects. J Lab Clin Med 1996, 128:585.
11. Schrier RW, Berl T, Anderson RJ Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979, 236:F321.
12. Czaplewski C, Kazmierkiewicz R, Ciarkowski J Molecular modeling of the human vasopressin V2 receptor/agonist complex. J Comput Aided Mol Des 1998, 12:275.
13. Ruiz-Opazo N, Akimoto K, Herrera VL Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory. Nat Med 1995, 1:1074.
14. Thibonnier M, Conarty DM, Preston JA, et al. Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999, 140:1301.
15. Bankir L Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 2001, 51:372.
16. Son MC, Brinton RD Vasopressin-induced calcium signaling in cultured cortical neurons. Brain Res 1998, 793:244.
17. Valenti G, Procino G, Tamma G, et al. Minireview: aquaporin 2 trafficking. Endocrinology 2005, 146:5063.
18. Kuwahara M, Fushimi K, Terada Y, et al. cAMP-dependent phosphorylation stimulates water permeability of aquaporin-collecting duct water channel protein expressed in Xenopus oocytes. J Biol Chem 1995, 270:10384.
19. Itoh T, Rai T, Kuwahara M, et al. Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. Biochem Biophys Res Commun 2005, 330:832.
20. Harris HW, Zeidel ML. Cell biology of vasopressin. In Brenner BM (ed.): The Kidney, 5th edn (Philadelphia, PA: Saunders), pp 516-531, 1996.
21. Ecelbarger CA, Nielsen S, Olson BR, et al. Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J Clin Invest 1997, 99:1852.
22. Tian Y, Sandberg K, Murase T, et al. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis. Endocrinology 2000, 141:307.
23. Hebert SC, Brown EM, Harris HW Role of the Ca2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997, 200:295.
24. Marples D, Frokiaer J, Dorup J, et al. Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest 1996, 97:1960.
25. Apostol E, Ecelbarger CA, Terris J, et al. Reduced renal medullary water channel expression in puromycin aminonucleoside-induced nephrotic syndrome. J Am Soc Nephrol 1997, 8:15.
26. Wilke C, Sheriff S, Soleimani M, Amlal H Vasopressin-independent regulation of collecting duct aquaporin-2 in food deprivation. Kidney Int 2005, 67:201.
27. Stachenfeld NS, Taylor HS, Leone CA, Keefe DL Estrogen effects on urine concentrating response in young women. J Physiol 2003, 552:869.
28. Ge Y, Stricklett PK, Hughes AK, et al. Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure. Am J Physiol Renal Physiol 2005, 289:F692.
29. Walker RJ, Weggery S, Bedford JJ, et al. Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Kidney Int 2005, 67:291.
30. Agnoli GC, Borgatti R, Cacciari M, et al. Low-dose desmopressin infusion: renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids. Prostaglandins Leukot Essent Fatty Acids 2002, 67:263.
31. Koukoulas I, Risvanis J, Douglas-Denton R, et al. Vasopressin receptor expression in the placenta. Biol Reprod 2003, 69:679.
32. Herin P, Kim JK, Schrier RW, et al. Ovine fetal response to water deprivation: aspects on the role of vasopressin. Q J Exp Physiol 1988, 73:931.
33. Irion GL, Mack CE, Clark KE Fetal hemodynamic and fetoplacental vascular response to exogenous arginine vasopressin. Am J Obstet Gynecol 1990, 162:1115.
34. Towstoless MK, Congiu M, Coghlan JP, Wintour EM Placental and renal control of plasma osmolality in chronically cannulated ovine fetus. Am J Physiol 1987, 253:R389.
35. Liu H, Koukoulas I, Ross MC, et al. Quantitative comparison of placental expression of three aquaporin genes. Placenta 2004, 25:475.
36. Wang S, Chen J, Beall M, et al. Expression of aquaporin 9 in human chorioamniotic membranes and placenta. Am J Obstet Gynecol 2004, 191:2160.
37. Ishibashi K, Morinaga T, Kuwahara M, et al. Cloning and identification of a new member of water channel (AQP10) as an aquaglyceroporin. Biochim Biophys Acta 2002, 1576:335.
38. Mobasheri A, Wray S, Marples D Distribution of AQP2 and AQP3 water channels in human tissue microarrays. J Mol Histol 2005, 36:1.
39. Bell RJ, Laurence BM, Meehan PJ, et al. Regulation and function of arginine vasopressin in pregnant sheep. Am J Physiol 1986, 250:F777.
40. Buemi M, D'Anna R, Di Pasquale G, et al. Urinary excretion of aquaporin-2 water channel during pregnancy. Cell Physiol Biochem 2001, 11:203.
41. Stegner H, Leake RD, Palmer SM, Fisher DA Permeability of the sheep placenta to 125I-arginine vasopressin. Dev Pharmacol Ther 1984, 7:140.
42. Desai M, Guerra C, Wang S, Ross MG Programming of hypertonicity in neonatal lambs: resetting of the threshold for vasopressin secretion. Endocrinology 2003, 144:4332.
43. Oosterbaan HP, Swaab DF, Boer GJ Oxytocin and vasopressin in the rat do not readily pass from the mother to the amniotic fluid in late pregnancy. J Dev Physiol 1985, 7:55.
44. Mastorakos G, Ilias I Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 2003, 997:136.
45. Gilbert WM, Cheung CY, Brace RA Rapid intramembranous absorption into the fetal circulation of arginine vasopressin injected intraamniotically. Am J Obstet Gynecol 1991, 164:1013.
46. Oosterbaan HP, Swaab DF Amniotic oxytocin and vasopressin in relation to human fetal development and labour. Early Hum Dev 1989, 19:253.
47. Young SF, Smith JL, Figueroa JP, Rose JC Ontogeny and effect of cortisol on vasopressin-1b receptor expression in anterior pituitaries of fetal sheep. Am J Physiol Regul Integr Comp Physiol 2003, 284:R51.
48. Shi L, Guerra C, Yao J, Xu Z Vasopressin mechanism-mediated pressor responses caused by central angiotensin II in the ovine fetus. Pediatr Res 2004, 56:756.
49. Bonilla-Felix M Development of water transport in the collecting duct. Am J Physiol Renal Physiol 2004, 287:F1093.
50. Bajoria R, Ward S, Sooranna SR Influence of vasopressin in the pathogenesis of oligohydramnios-polyhydramnios in monochorionic twins. Eur J Obstet Gynecol Reprod Biol 2004, 113:49.
51. Robillard JE, Weitzman RE Developmental aspects of the fetal renal response to exogenous arginine vasopressin. Am J Physiol 1980, 238:F407.
52. Ramin SM, Porter JC, Gilstrap LC, Rosenfeld CR Stress hormones and acid-base status of human fetuses at delivery. J Clin Endocrinol Metab 1991, 73:182.
53. Pochard JL, Lutz-Bucher B Vasopressin and oxytocin levels in human neonates. Relationships with the evolution of labour and beta-endorphins. Acta Paediatr Scand 1986, 75:774.
54. Zelenina M, Zelenin S, Aperia A Water channels (aquaporins) and their role for postnatal adaptation. Pediatr Res 2005, 57:47R.
55. Polacek E, Vocel J, Neugebauerova L, et al. The osmotic concentrating ability in healthy infants and children. Arch Dis Child 1965, 40:291.
56. Svenningsen NW, Aronson AS Postnatal development of renal concentration capacity as estimated by DDAVP-test in normal and asphyxiated neonates. Biol Neonate 1974, 25:230.
57. Winberg J Renal function in water-losing syndrome due to lower urinary tract obstruction before and after treatment. Acta Paediatr 1959, 48:149.
58. Ammar A, Roseau S, Butlen D Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct. Am J Physiol 1992, 262:F546.
59. Bonilla-Felix M, Vehaskari VM, Hamm LL Water transport in the immature rabbit collecting duct. Pediatr Nephrol 1999, 13:103.
60. Gengler WR, Forte LR Neonatal development of rat kidney adenyl cyclase and phosphodiesterase. Biochim Biophys Acta 1972, 279:367.
61. Quigley R, Chakravarty S, Baum M Antidiuretic hormone resistance in the neonatal cortical collecting tubule is mediated in part by elevated phosphodiesterase activity. Am J Physiol Renal Physiol 2004, 286:F317.
62. Sulyok E Renal response to vasopressin in premature infants: what is new?. Biol Neonate 1988, 53:212.
63. Celsi G, Jakobsson B, Aperia A Influence of age on compensatory renal growth in rats. Pediatr Res 1986, 20:347.
64. Tsukahara H, Hata I, Sekine K, et al. Renal water channel expression in newborns: measurement of urinary excretion of aquaporin-2. Metabolism 1998, 47:1344.
65. Devuyst O, Burrow CR, Smith BL, et al. Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease. Am J Physiol 1996, 271:F169.
66. Nyul Z, Vajda Z, Vida G, Sulyok E, et al. Urinary aquaporin-2 excretion in preterm and full-term neonates. Biol Neonate 2002, 82:17.
67. Bonilla-Felix M, Jiang W Aquaporin-2 in the immature rat: expression, regulation, and trafficking. J Am Soc Nephrol 1997, 8:1502.
68. Yasui M, Serlachius E, Lofgren M, et al. Perinatal changes in expression of aquaporin-4 and other water and ion transporters in rat lung. J Physiol 1997, 505:3.
69. Yamamoto T, Sasaki S, Fushimi K, et al. Expression of AQP family in rat kidneys during development and maturation. Am J Physiol 1997, 272:F198.
70. Rutishauser J, Boni-Schnetzler M, Boni J, et al. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 1996, 81:192.
71. Knoers NVAM, Monnens LAH: Nephrogenic diabetes insipidus. In Avner ED, Harmon WE, Niaudet P (Eds), Pediatric Nephrology 5th edn (pp. 777-787). Philadelphia, PA: Lippincott Williams and Wilkins, 2004.
72. Knoers NV, Deen PM Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 2001, 16:1146.
73. Abernethy LJ, Qunibi MA, Smith CS Normal MR appearances of the posterior pituitary in central diabetes insipidus associated with septo-optic dysplasia. Pediatr Radiol 1997, 27:45.
74. Garofeanu CG, Weir M, Rosas-Arellano MP, et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 2005, 45:626.
75. Baylis PH The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 2003, 35:1495.
76. Price JF, Towbin JA, Denfield SW, et al. Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure. Circulation 2004, 109:2550.
77. Rocha JL, Friedman E, Boson W, et al. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus. Hum Mutat 1999, 14:233.
78. Kavvadia V, Greenough A, Dimitriou G, et al. A comparison of arginine vasopressin levels and fluid balance in the perinatal period in infants who did and did not develop chronic oxygen dependency. Biol Neonate 2000, 78:86.
79. Kobayashi R, Iguchi A, Nakajima M, et al. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation. Bone Marrow Transplant 2004, 34:975.
80. Papadimitriou A, Kipourou K, Manta C, et al. Adipsic hypernatremia syndrome in infancy. J Pediatr Endocrinol Metab 1997, 10:547.
81. Henry JP, Gauer OH, Sieker HO The effect of moderate changes in blood volume on left and right atrial pressures. Circ Res 1956, 4:91.
82. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981, 28:89.
83. Kangawa K, Matsuo H Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 1984, 118:131.
84. Sudoh T, Kangawa K, Minamino N, Matsuo H A new natriuretic peptide in porcine brain. Nature 1988, 332:78.
85. Sudoh T, Minamino N, Kangawa K, Matsuo H C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990, 168:863.
86. de Bold AJ, Ma KK, Zhang Y, et al. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 2001, 79:705.
87. Kuhn M Cardiac and intestinal natriuretic peptides: insights from genetically modified mice. Peptides 2005, 26:1078.
88. Vesely DL Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol 2003, 285:F167.
89. Ruskoaho H Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992, 44:479.
90. Chusho H, Tamura N, Ogawa Y, et al. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 2001, 98:4016.
91. Levin ER, Gardner DG, Samson WK Natriuretic peptides. N Engl J Med 1998, 339:321.
92. McGrath MF, de Bold AJ Determinants of natriuretic peptide gene expression. Peptides 2005, 26:933.
93. Joubert S, Jossart C, McNicoll N, De Lean A Atrial natriuretic peptide-dependent photolabeling of a regulatory ATP-binding site on the natriuretic peptide receptor-A. FEBS J 2005, 272:5572.
94. Inoue T, Nonoguchi H, Tomita K Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct. Cardiovasc Res 2001, 51:470.
95. Garbers DL, Lowe DG Guanylyl cyclase receptors. J Biol Chem 1994, 269:30741.
96. Fuller F, Porter JG, Arfsten AE, et al. Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem 1988, 263:9395.
97. Matsukawa N, Grzesik WJ, Takahashi N, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 1999, 96:7403.
98. Nonoguchi H, Knepper MA, Manganiello VC Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats. J Clin Invest 1987, 79:500.
99. Terada Y, Moriyama T, Martin BM, et al. RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney. Am J Physiol Renal Physiol 1991, 261:1080.
100. Gunning ME, Brenner BM Natriuretic peptides and the kidney: current concepts. Kidney Int Suppl 1992, 38:S127.
101. Lewko B [Interaction between guanylate cyclases in the kidney glomerulus]. Postepy Hig Med Dosw 1999, 53:225.
102. Nonoguchi H, Sands JM, Knepper MA ANF inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney. Am J Physiol 1989, 256:F179.
103. Zeidel ML, Silva P, Brenner BM, Seifter JL cGMP mediates effects of atrial peptides on medullary collecting duct cells. Am J Physiol 1987, 252:F551.
104. Zeidel ML, Kikeri D, Silva P, et al. Atrial natriuretic peptides inhibit conductive sodium uptake by rabbit inner medullary collecting duct cells. J Clin Invest 1988, 82:1067.
105. Sonnenberg H, Honrath U, Chong CK, Wilson DR Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 1986, 250:F963.
106. Harris PJ, Thomas D, Morgan TO Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 1987, 326:697.
107. Nonoguchi H, Sands JM, Knepper MA Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct. J Clin Invest 1988, 82:1383.
108. Nonoguchi H, Tomita K, Marumo F Effects of atrial natriuretic peptide and vasopressin on chloride transport in long- and short-looped medullary thick ascending limbs. J Clin Invest 1992, 90:349.
109. Baum M, Toto RD Lack of a direct effect of atrial natriuretic factor in the rabbit proximal tubule. Am J Physiol 1986, 250:F66.
110. Capasso G, Rosati C, Giordano DR, De Santo NG Atrial natriuretic peptide has no direct effect on proximal tubule sodium and water reabsorption. Pflugers Arch 1989, 415:336.
111. Kondo Y, Imai M, Kangawa K, Matsuo H Lack of direct action of alpha-human atrial natriuretic polypeptide on the in vitro perfused segments of Henle's loop isolated from rabbit kidney. Pflugers Arch 1986, 406:273.
112. Herten M, Lenz W, Gerzer R, Drummer C The renal natriuretic peptide urodilatin is present in human kidney. Nephrol Dial Transplant 1998, 13:2529.
113. Villarreal D, Freeman RH, Taraben A, Reams GP Modulation of renin secretion by atrial natriuretic factor prohormone fragment 31-67. Am J Med Sci 1999, 318:330.
114. Burnett JC, Granger JP, Opgenorth TJ Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984, 247:F863.
115. Aguilera G Differential effects of atrial natriuretic factor on angiotensin II- and adrenocorticotropin-stimulated aldosterone secretion. Endocrinology 1987, 120:299.
116. Holtwick R, Gotthardt M, Skryabin B, et al. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 2002, 99:7142.
117. Nakayama T The genetic contribution of the natriuretic peptide system to cardiovascular diseases. Endocr J 2005, 52:11.
118. Calderone A, Thaik CM, Takahashi N, et al. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 1998, 101:812.
119. Cao L, Gardner DG Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 1995, 25:227.
120. Charloux A, Piquard F, Doutreleau S, et al. Mechanisms of renal hyporesponsiveness to ANP in heart failure. Eur J Clin Invest 2003, 33:769.
121. Stevens TL, Wei CM, Aahrus LL, et al. Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor. Hypertension 1994, 23:613.
122. Ledoux S, Dussaule JC, Chatziantoniou C, et al. Protein kinase A activity modulates natriuretic peptide-dependent cGMP accumulation in renal cells. Am J Physiol 1997, 272:C82.
123. Aviv R, Gurbanov K, Hoffman A, et al. Urinary neutral endopeptidase 24.11 activity: modulation by chronic salt loading. Kidney Int 1995, 47:855.
124. Ebihara F, Di Marco GS, Juliano MA, Casarini DE Neutral endopeptidase expression in mesangial cells. J Renin Angiotensin Aldosterone Syst 2003, 4:228.
125. Bianciotti LG, de Bold AJ Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension. Cardiovasc Res 2001, 49:808.
126. Boric MP, Bravo JA, Corbalan M, et al. Interactions between bradykinin and ANP in rat kidney in vitro: inhibition of natriuresis and modulation of medullary cyclic GMP. Biol Res 1998, 31:281.
127. McDougall JG, Yates NA Natriuresis and inhibition of Na+/K(+)-ATPase: modulation of response by physiological manipulation. Clin Exp Pharmacol Physiol Suppl 1998, 25:S57.
128. Yoshimura T, Yoshimura M, Yasue H, et al. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol 1994, 140:393.
129. Mulay S, Varna DR Placental barrier to atrial natriuretic peptide in rats. Can J Physiol Pharmacol 1989, 67:1.
130. Graham CH, Watson JD, Blumenfeld AJ, Pang SC Expression of atrial natriuretic peptide by third-trimester placental cytotrophoblasts in women. Biol Reprod 1996, 54:834.
131. Cai WQ, Terenghi G, Bodin P, et al. In situ hybridization of atrial natriuretic peptide mRNA in the endothelial cells of human umbilical vessels. Histochemistry 1993, 100:277.
132. Itoh H, Sagawa N, Hasegawa M, et al. Transforming growth factor-beta stimulates, and glucocorticoids and epidermal growth factor inhibit brain natriuretic peptide secretion from cultured human amnion cells. J Clin Endocrinol Metab 1994, 79:176.
133. Cameron VA, Aitken GD, Ellmers LJ, et al. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 1996, 137:817.
134. Huang W, Lee D, Yang Z, et al. Evidence for atrial natriuretic peptide-(5-28) production by rat placental cytotrophoblasts. Endocrinology 1992, 131:919.
135. Inglis GC, Kingdom JC, Nelson DM, et al. Atrial natriuretic hormone: a paracrine or endocrine role within the human placenta?. J Clin Endocrinol Metab 1993, 76:1014.
136. Hatjis CG, Grogan DM Atrial natriuretic peptide receptors in normal human placentas. Am J Obstet Gynecol 1988, 159:587.
137. Zhang LC, Liang GD, Zhang YH, et al. Distribution and characteristics of placental ANP receptors in normal and hypertensive pregnancy. Chin Med J 1992, 105:39.
138. McQueen J, Kingdom JC, Whittle MJ, Connell JM Characterization of atrial natriuretic peptide receptors in human fetoplacental vasculature. Am J Physiol 1993, 264:H798.
139. Itoh H, Zheng J, Bird IM, et al. Basic FGF decreases clearance receptor of natriuretic peptides in fetoplacental artery endothelium. Am J Physiol 1999, 277:R541.
140. Szukiewicz D, Szukiewicz A, Maslinska D, Markowski M In vitro effect of bioactive natriuretic peptides on perfusion pressure in placentas from normal and pre-eclamptic pregnancies. Arch Gynecol Obstet 1999, 263:37.
141. Thomsen JK, Storm TL, Thamsborg G, et al. Atrial natriuretic peptide concentrations in pre-eclampsia. Br Med J (Clin Res Ed) 1987, 294:1508.
142. Fievet P, Fournier A, de Bold A, et al. Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism. Am J Hypertens 1988, 1:16.
143. Miyamoto S, Shimokawa H, Sumioki H, Nakano H Physiologic role of endogenous human atrial natriuretic peptide in preeclamptic pregnancies. Am J Obstet Gynecol 1989, 160:155.
144. Hatjis CG, Greelish JP, Kofinas AD, et al. Atrial natriuretic factor maternal and fetal concentrations in severe preeclampsia. Am J Obstet Gynecol 1989, 161:1015.
145. Bond AL, August P, Druzin ML, et al. Atrial natriuretic factor in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989, 160:1112.
146. McQueen J, Jardine A, Kingdom J, et al. Interaction of angiotensin II and atrial natriuretic peptide in the human fetoplacental unit. Am J Hypertens 1990, 3:641.
147. Holcberg G, Kossenjans W, Brewer A, et al. Selective vasodilator effects of atrial natriuretic peptide in the human placental vasculature. J Soc Gynecol Investig 1995, 2:1.
148. Stebbing PN, Gude NM, King RG, Brennecke SP Alpha-atrial natriuretic peptide-induced attenuation of vasoconstriction in the fetal circulation of the human isolated perfused placenta. J Perinat Med 1996, 24:253.
149. Grunewald C, Nisell H, Jansson T, et al. Possible improvement in uteroplacental blood flow during atrial natriuretic peptide infusion in preeclampsia. Obstet Gynecol 1994, 84:235.
150. Zeller R, Bloch KD, Williams BS, et al. Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev 1987, 1:693.
151. Wei YF, Rodi CP, Day ML, et al. Developmental changes in the rat atriopeptin hormonal system. J Clin Invest 1987, 79:1325.
152. Cheung CY, Gibbs DM, Brace RA Atrial natriuretic factor in maternal and fetal sheep. Am J Physiol 1987, 252:E279.
153. Robillard JE, Nakamura KT, Varille VA, et al. Ontogeny of the renal response to natriuretic peptide in sheep. Am J Physiol 1988, 254:F634.
154. Deloof S, Chatelain A Effect of blood volume expansion on basal plasma atrial natriuretic factor and adrenocorticotropic hormone secretions in the fetal rat at term. Biol Neonate 1994, 65:390.
155. Cameron VA, Ellmers LJ Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 2003, 144:2191.
156. Cheung CY, Roberts VJ Developmental changes in atrial natriuretic factor content and localization of its messenger ribonucleic acid in ovine fetal heart. Am J Obstet Gynecol 1993, 169:1345.
157. Rosenfeld CR, Samson WK, Roy TA, et al. Vasoconstrictor-induced secretion of ANP in fetal sheep. Am J Physiol 1992, 263:E526.
158. Cheung CY Regulation of atrial natriuretic factor secretion and expression in the ovine fetus. Neurosci Biobehav Rev 1995, 19:159.
159. Mir TS, Laux R, Hellwege HH, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003, 112:896.
160. Bierd TM, Kattwinkel J, Chevalier RL, et al. Interrelationship of atrial natriuretic peptide, atrial volume, and renal function in premature infants. J Pediatr 1990, 116:753.
161. Ekblad H, Kero P, Vuolteenaho O, et al. Atrial natriuretic peptide in the preterm infant. Lack of correlation with natriuresis and diuresis. Acta Paediatr 1992, 81:978.
162. Shaffer SG, Geer PG, Goetz KL Elevated atrial natriuretic factor in neonates with respiratory distress syndrome. J Pediatr 1986, 109:1028.
163. Semmekrot B, Roseau S, Vassent G, Butlen D Developmental patterns of renal atrial natriuretic peptide receptors: [125I]alpha-rat atrial natriuretic peptide binding in glomeruli and inner medullary collecting tubules microdissected from kidneys of young rats. Mol Cell Endocrinol 1990, 68:35.
164. Chevalier RL, Fern RJ, Garmey M, et al. Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat. Am J Physiol 1992, 262:F417.
165. Midgley J, Modi N, Littleton P, et al. Atrial natriuretic peptide, cyclic guanosine monophosphate and sodium excretion during postnatal adaptation in male infants below 34 weeks gestation with severe respiratory distress syndrome. Early Hum Dev 1992, 28:145.
166. Norling LL, Vaughan CA, Chevalier RL Maturation of cGMP response to ANP by isolated glomeruli. Am J Physiol 1992, 262:F138.
167. Stephenson TJ, Broughton Pipkin F, Hetmanski D, Yoxall B Atrial natriuretic peptide in the preterm newborn. Biol Neonate 1994, 66:22.
168. Itoh H, Sagawa N, Hasegawa M, et al. Brain natriuretic peptide levels in the umbilical venous plasma are elevated in fetal distress. Biol Neonate 1993, 64:18.
169. Andersson S, Hallman M, Tikkanen I, Fyhrquist F Birth stress increase fetal atrial natriuretic factor. Am J Obstet Gynecol 1990, 162:872.
170. Itoh H, Sagawa N, Hasegawa M, et al. Umbilical venous guanosine 3',5'-cyclic phosphate (cGMP) concentration increases in asphyxiated newborns. Reprod Fertil Dev 1995, 7:1515.
171. Yamada J, Fujimori K, Ispida T, et al. Plasma endothelin-1 and atrial natriuretic peptide levels during prolonged (24-h) non-acidemic hypoxemia in fetal goats. J Matern Fetal Med 2001, 10:409.
172. Okumura A, Toyota N, Hayakawa F, et al. Cerebral hemodynamics during early neonatal period in preterm infants with periventricular leukomalacia. Brain Dev 2002, 24:693.
173. Choi BM, Lee KH, Eun BL, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005, 115:e255.
174. Modi N, Betremieux P, Midgley J, Hartnoll G Postnatal weight loss and contraction of the extracellular compartment is triggered by atrial natriuretic peptide. Early Hum Dev 2000, 59:201.
175. Rozycki HJ, Baumgart S Atrial natriuretic factor and postnatal diuresis in respiratory distress syndrome. Arch Dis Child 1991, 66:43.
176. Bauer K, Buschkamp S, Marcinkowski M, et al. Postnatal changes of extracellular volume, atrial natriuretic factor, and diuresis in a randomized controlled trial of high-frequency oscillatory ventilation versus intermittent positive-pressure ventilation in premature infants <30 weeks gestation. Crit Care Med 2000, 28:2064.
177. Kojima T, Hirata Y, Fukuda Y, et al. Plasma atrial natriuretic peptide and spontaneous diuresis in sick neonates. Arch Dis Child 1987, 62:667.
178. Ronconi M, Fortunato A, Soffiati G, et al. Vasopressin, atrial natriuretic factor and renal water homeostasis in premature newborn infants with respiratory distress syndrome. J Perinat Med 1995, 23:307.
179. Onal EE, Dilmen U, Adam B, et al. Serum atrial natriuretic peptide levels in infants with transient tachypnea of the newborn. J Matern Fetal Neonatal Med 2005, 17:145.
180. Tulassay T, Rascher W, Seyberth HW, et al. Role of atrial natriuretic peptide in sodium homeostasis in premature infants. J Pediatr 1986, 109:1023.
181. Kojima T, Fukuda Y, Hirata Y, et al. Effects of aldosterone and atrial natriuretic peptide on water and electrolyte homeostasis of sick neonates. Pediatr Res 1989, 25:591.
182. Holmstrom H, Hall C, Thaulow E Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 2001, 90:184.
183. Holmstrom H, Omland T Editorial Board: Natriuretic peptides as markers of patent ductus arteriosus in preterm infants. Clin Sci 2002, 103:79.
184. Puddy VF, Amirmansour C, Williams AF, Singer DR Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci 2002, 3:75.
185. Kaapa P, Seppanen M, Kero P, et al. Hemodynamic control of atrial natriuretic peptide plasma levels in neonatal respiratory distress syndrome. Am J Perinatol 1995, 12:235.
186. Pesonen E Role of natriuretic hormones in the diagnosis of patent ductus arteriosus in newborn infants. Acta Paediatr 2001, 90:363.
187. Reynolds EW, Ellington JG, Vranicar M, Bada HS Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 2004, 114:1297.
188. Holmgren D, Westerlind A, Lundberg PA, Wahlander H Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imaging 2005, 25:263.
189. Costello JM, Backer CL, Checchia PA, et al. Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 2004, 25:347.
190. Ootaki Y, Yamaguchi M, Yoshimura N, et al. Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease. J Thorac Cardiovasc Surg 2003, 126:1411.
191. Oberhansli I, Mermillod B, Favre H, et al. Atrial natriuretic factor in patients with congenital heart disease: correlation with hemodynamic variables. J Am Coll Cardiol 1990, 15:1438.